[Proceedings: Immunosuppression and treatment of psoriasis using cytostatic agents].
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001634:Bibliographies as Topic; D056486:Chemical and Drug Induced Liver Injury; D006801:Humans; D006918:Hydroxyurea / Q000009:adverse effects / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008297:Male; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy / Q000628:therapy*
D000970:Antineoplastic Agents; D001379:Azathioprine; D006918:Hydroxyurea; D008727:Methotrexate
Immunsuppression und Psoriasis-Behandlung mit Cytostatica.